Ibex Technologies (TSE:IBT) has released an update.
Ibex Technologies Inc. reports a 12% revenue increase in the second quarter and a 15% uptick over six months, attributed to the robust hemostasis market. Despite higher revenues, net earnings decreased due to expenses from a proposed acquisition by BBI Solutions OEM Limited and increased income taxes. Shareholders are set to vote on the acquisition, with shares priced at $1.45, as recommended by IBEX’s Board of Directors.
For further insights into TSE:IBT stock, check out TipRanks’ Stock Analysis page.
